Navigation Links
Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
Date:9/3/2013

mentioned companies to our subscriber base and the investing public.
  • If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  • For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

  • COMPLIANCE PROCEDURE

    Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

    NOT FINANCIAL ADVICE

    Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

    NO WARRANTY OR LIABILITY ASSUMED

    Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for
    '/>"/>

    SOURCE Analysts' Corner
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
    2. Magellan Diagnostics Receives FDA Clearance for LeadCare Ultra Bench-top Clinical Lead Analyzer
    3. Cellular Biomedicine Group Announces Completion of Patient Enrollment for Phase I Clinical Trial for Liver Cancer
    4. Selexys Pharmaceuticals Initiates SUSTAIN Phase 2 Clinical Trial in Sickle Cell Patients with Pain Crises
    5. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
    6. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
    7. Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
    8. MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
    9. Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update
    10. Sanarias Malaria Vaccine Yields Unprecedented Protection In Phase 1 Clinical Trial
    11. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for Second Quarter 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/31/2015)... , Aug. 31, 2015 The Wolf ... statewide since Pennsylvania State Police ... drug kits, naloxone. Heroin and opioid overdose ... Pennsylvania , killing more individuals than those ... 2,400 Pennsylvanians died from a drug overdose. ...
    (Date:8/31/2015)... Calif. , Aug. 31, 2015  Regulatory ... and government, where regulations are often strict and ... is driving a demand for professionals who have ... these regulations across a product lifecycle and demonstrate ... The University of California, Irvine Extension , ...
    (Date:8/31/2015)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ), the nation,s largest ... Chairman & CEO, and Sean Whelan , CFO, will ... Hagerman and Mr. Whelan are scheduled to participate in the ... on Wednesday, September 9, 2015 at 1:45 PM ET. ... to participate in the Robert W. Baird 2015 Healthcare Conference ...
    Breaking Medicine Technology:Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Diplomat to Participate in Upcoming Investor Conferences 2
    ... PALO ALTO, Calif., Sept. 11 Jazz,Pharmaceuticals, Inc. (Nasdaq: ... completed participation in the first Phase III pivotal clinical ... The JZP-6 Phase III clinical trial program includes ... 550,fibromyalgia patients at 65 centers in the U.S. The ...
    ... 10 As a surgeon and clinical,instructor, Dr. ... the,growing number of patients contracting ... and dying ... aware that infections are quickly,spreading beyond the healthcare ... A 2004 study supervised by Dr. Deal tracked ...
    Cached Medicine Technology:Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia 2Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia 3Doctor Declares War on Hospital Infections, Patents MRSA-Killing Machine 2
    (Date:8/31/2015)... , ... August 31, 2015 , ... In an ... Press, the expert guest author addressed the topic of treating back pain caused by ... while steroids were shown to slightly improve physical function in patients suffering from a ...
    (Date:8/31/2015)... ... August 31, 2015 , ... Wound Care Advantage, a leader ... Introduction to Hyperbaric Medicine Course. The next UHMS approved 40-hour Introduction to Hyperbaric ... in Long Beach, CA. The meeting is open for registration from physicians, clinicians ...
    (Date:8/31/2015)... ... August 31, 2015 , ... ... management program that is unique to the Lake Orion area. This program is ... County. , WEmovestrong’s weight management program will incorporate group fitness and nutritional ...
    (Date:8/31/2015)... Orion, Clarkston, Metamora, Michigan (PRWEB) , ... August ... ... Movestrong, has launched pre and postnatal fitness classes. , Starting September ... The classes are called "The Mom Bod" and "Healthy Body, Healthy Baby." , ...
    (Date:8/31/2015)... Los Angeles, CA (PRWEB) , ... August 31, 2015 , ... ... to start from and those who are interested in learning more about the procedure ... Dr. Parsa Mohebi. , Internationally recognized hair transplant surgeon Parsa Mohebi will be ...
    Breaking Medicine News(10 mins):Health News:Article on Steroid Use for Back Pain Highlights the Effectiveness of Surgery in Treating Disk Pain, says Dr. Seyed M. Rezaian 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2
    ... add anti-smoking public service announcements to all DVD releases ... Attorney General // Joseph Curran initiated the petition after ... smoking in movies are more likely to begin smoking.' ... sign their names on a letter he sent to ...
    ... claim of having produced and purified stem cells from human ... in the British medical fraternity. ,The Guardian reported Friday ... impose tighter curbs on clinics in India that make extravagant ... doctor whose claims have evoked some concern here is Geeta ...
    ... licensed therapists do is no laughing matter. These ... 49 laughing therapists recently passed their // examinations and ... their immune system, and in general to help prevent ... the organizing Nihon Medical School., ,A doctor herself, ...
    ... high-risk medication by the FDA, doctors have been found to ... patients found to receive // such drugs was nearly ... and Harvard Pilgrim Health Care. ,The response of the ... variable, with noncompliance rates soaring from 0.3 % to 49.6%. ...
    ... a King County Superior Court jury in Seattle, Dr. Charles ... two counts // of rape and two counts of indecent ... treatment. ,Momah could face 16 years in prison if ... ,Momah pleaded not guilty last year to two counts ...
    ... performed a rare mother-to-son nerve transplant on Thursday, hoping to ... surgery on Nick Anderson of Atco, N.J., went as planned, ... in a few months, said Eric Vohr, a spokesman for ... success in three months, in about a year they should ...
    Cached Medicine News:Health News:British Scientists Doubt Delhi Doctor’s Stem Cell Claim 2Health News:Are You Ill? Have A Hard Laugh! 2Health News:Doctors Do Not Excise Sufficient Caution While Prescribing High-Risk Drugs 2Health News:Doctors Finish Mother-To-Son Nerve Surgery 2
    ... Erythropoietin (EPO) is the primary known ... The predicted molecular weight of human EPO ... circulating form of EPO has an estimated ... itself appears to have a unique structure, ...
    ... the parafollicular C-cells of the thyroid gland ... major action of calcitonin is to lower ... resulting in decreased mobilization of calcium from ... in conditions associated with high levels of ...
    ... (hCG) is a two chain (alpha- and ... tissue of the placenta and is normally ... Produced by the trophoblastic epithelium of the ... luteum in the early stages of pregnancy. ...
    ... Compensating for movement is ... in wheelchairs. Thats why ... exclusive technology to do ... with state-of-the-art technology, these ...
    Medicine Products: